DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look into the exploratory, open label Phase 2a study. In an open-label exploratory study, 36 subjects with mild to moderate disease (MMSE 14-26) were randomized to receive 1 of 4 doses …
Phase 2b Trial Showed Positive Results In Slowing Cognitive Decline High Point, North Carolina (September 7, 2016) vTv Therapeutics Inc. (NASDAQ:VTVT) today announced the completion of enrollment for Part A of STEADFAST (Single Trial Evaluating Alzheimer’s Disease Following Addition to Symptomatic Therapy), vTv’s Phase 3 placebo-controlled trial of azeliragon, an oral antagonist of the Receptor …
Does this make sense? Alzheimer’s disease is the most expensive disease facing our nation today and is set to increase like no other. Currently our country spends over $203 billion per year caring for those with Alzheimer’s, with two thirds of those costs paid by Medicare and Medicaid. Without …
Music can be powerful for people suffering from Alzheimer’s disease and related dementias, even in the very late stages of the disease. Music can affect mood, manage stress-induced agitation, stimulate positive interactions, facilitate cognitive function, and coordinate motor movements. Response to rhythm hardly requires any cognitive or mental processing. They are affected by the …
For those who are struggling with memory loss, a memory screen is a step in the right direction to keeping their minds healthy. Apply for a FREE memory screen today!
